Oxidative stress occurs early in Down syndrome pregnancy: A redox proteomics analysis of amniotic fluid-Reference-Cited by-同舟云学术

Oxidative stress occurs early in Down syndrome pregnancy: A redox proteomics analysis of amniotic fluid

Published:2011-02-24 Issue:3-4 Volume:5 Page:167-178
ISSN:1862-8346
Container-title:PROTEOMICS - Clinical Applications
language:en
Short-container-title:Prot. Clin. Appl.

Author:

Perluigi Marzia,di Domenico Fabio,Fiorini Ada,Cocciolo Annalisa,Giorgi Alessandra,Foppoli Cesira,Butterfield D. Allan,Giorlandino Maurizio,Giorlandino Claudio,Eugenia Schininà M.,Coccia Raffaella

Funder

Artemisia Medical Center of Rome

Publisher

Wiley

Subject

Clinical Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/prca.201000121/fullpdf

Reference74 articles.

1. Coenzyme Q10 and oxidative imbalance in Down syndrome: biochemical and clinical aspects;Tiano;Biofactors,2008

2. Understanding the basis for Down syndrome phenotypes;Roper;PLoS Genet.,2006

3. Multiple evidence for an early age pro-oxidant state in Down syndrome patients;Pallardo;Biogerontology,2006

4. Oxidative stress and neural dysfunction in Down syndrome;Iannello;J. Neural Transm. Suppl.,1999

5. Biomarkers of oxidative stress are significantly elevated in Down syndrome;Jovanovic;Free Radic. Biol. Med.,1998

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Oxidative Stress in Trisomy 21 Phenotype;Cellular and Molecular Neurobiology;2023-10-11

2. Cellular senescence and premature aging in Down Syndrome;Mechanisms of Ageing and Development;2023-06

3. Mitochondria Have Made a Long Evolutionary Path from Ancient Bacteria Immigrants within Eukaryotic Cells to Essential Cellular Hosts and Key Players in Human Health and Disease;Current Issues in Molecular Biology;2023-05-19

4. Transition from Animal-Based to Human Induced Pluripotent Stem Cells (iPSCs)-Based Models of Neurodevelopmental Disorders: Opportunities and Challenges;Cells;2023-02-07

5. CELLULAR STRESS RESPONSE (HORMESIS) IN RESPONSE TO BIOACTIVE NUTRACEUTICALS WITH RELEVANCE TO ALZHEIMER DISEASE;Antioxidants & Redox Signaling;2023-01-19